Protein flexibility in docking and surface mapping

Quarterly Reviews of Biophysics

Volumn 45, Issue 3, 2012, Pages 301-343

  Lexa, Katrina W ^a   Carlson, Heather A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROTEIN;

ANIMAL; CHEMISTRY; DRUG DESIGN; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR DOCKING; REVIEW; SURFACE PROPERTY;

ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR DOCKING SIMULATION; PROTEINS; SURFACE PROPERTIES;

EID: 84865237493     PISSN: 00335835     EISSN: 14698994     Source Type: Journal    
DOI: 10.1017/S0033583512000066     Document Type: Review

References (179)

1. ABAGYAN, R., TOTROV, M. & KUZNETSOV, D. A. (1994). ICM-a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. Journal of Computational Chemistry 15, 488-506.
2. ALBERTS, I. L., TODOROV, N. P. & DEAN, P. M. (2005a). Receptor flexibility in de novo ligand design and docking. Journal of Medicinal Chemistry 48, 6585-6596.
3. ALBERTS, I. L., TODOROV, N.P., KALLBLAD, P. & DEAN, P. M. (2005b). Ligand docking and design in a flexible receptor site. QSAR and Combinatorial Science 24, 503-507.
4. ALONSO, H., BLIZNYUK, A. A. & GREADY, J. E. (2006). Combining docking and molecular dynamic simulations in drug design. Medicinal Research Reviews 26, 531-568.
5. AMARO, R. E., BARON, R. & MCCAMMON, J. A. (2008). An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. Journal of Computer-Aided Molecular Design 22, 693-705.
6. ANDERSON, A. C., O'NEIL, R. H., SURTI, T. S. & STROUD, R. M. (2001). Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking. Chemistry and Biology 8, 445-457.
7. BABAKHANI, A., TALLEY, T. T., TAYLOR, P. & MCCAMMON, J. A. (2009). A virtual screening study of the acetylcho-line binding protein using a relaxed-complex approach. Computational Biology and Chemistry 33, 160-170.
8. BARAKAT, K., MANE, J., FRIESEN, D. & TUSZYNSKI, J. (2010). Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions. Journal of Molecular Graphics and Modelling 28, 555-568.
9. BARAKAT, K. & TUSZYNSKI, J. (2010). Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta. Journal of Molecular Graphics and Modelling 29, 702-716.
10. BARRIL, X. & MORLEY, S. D. (2005). Unveiling the full potential of flexible receptor docking using multiple crys-tallographic structures. Journal of Medicinal Chemistry 48, 4432-4443.
11. BERGER, C., WEBER-BORNHAUSER, S., EGGENBERGER, J., HANES, J., PLUCKTHUN, A. & BOSSHARD, H. R. (1999). Antigen recognition by conformational selection. FEBS Letters 450, 149-153.
12. BERMAN, H. M., BHAT, T. N., BOURNE, P. E., FENG, Z., GILLILAND, G., WEISSIG, H. & WESTBROOK, J. (2000). The Protein Data Bank and the challenge of structural genomics. Nature Structural Biology 7 (Suppl), 957-959.
13. BISSON, W. H., CHELTSOV, A. V., BRUEY-SEDANO, N., LIN, B., CHEN, J., GOLDBERGER, N., MAY, L.T., CHRISTOPOULOS, A., DALTON, J.T., SEXTON, P.M., ZHANG, X. K. & ABAGYAN, R. (2007). Discovery of an-tiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proceedings of the National Academy of Sciences of the United States of America 104, 11927-11932.
14. BOLSTAD, E. S. & ANDERSON, A. C. (2008). In pursuit of virtual lead optimization: the role of the receptor structure and ensembles in accurate docking. Proteins 73, 566-580.
15. BOLSTAD, E. S. & ANDERSON, A. C. (2009). In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking. Proteins 75, 62-74.
16. BOTTEGONI, G. (2011). Protein-ligand docking. Frontiers in Bioscience 16, 2289-2306.
17. BOTTEGONI, G., KUFAREVA, I., TOTROV, M. & ABAGYAN, R. (2008). A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE). Journal of Computer-Aided Molecular Design 22, 311-325.
18. BOTTEGONI, G., KUFAREVA, I., TOTROV, M. & ABAGYAN, R. (2009). Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking. Journal of Medicinal Chemistry 52, 397-406.
19. BOWMAN, A. L., NIKOLOVSKA-COLESKA, Z., ZHONG, H., WANG, S. & CARLSON, H. A. (2007). Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models. Journal of the American Chemical Society 129, 12809-12814.
20. BRENKE, R., KOZAKOV, D., CHUANG, G. Y., BEGLOV, D., HALL, D., LANDON, M.R., MATTOS, C. & VAJDA, S. (2009). Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques. Bioinformatics 25, 621-627.
21. BROUGHTON, H. B. (2000). A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening. Journal of Molecular Graphics and Modelling 18, 247-257, 302-244.
22. BUHRMAN, G., DE SERRANO, V. & MATTOS, C. (2003). Organic solvents order the dynamic switch II in Ras crystals. Structure 11, 747-751.
23. CARLSON, H. A., MASUKAWA, K. M. & MCCAMMON, J. A. (1999). Method for including the dynamic fluctuations of a protein in computer-aided drug design. Journal of Physical Chemistry A 103, 10213-10219.
24. CARLSON, H. A., MASUKAWA, K. M., RUBINS, K., BUSHMAN, F. D., JORGENSEN, W. L., LINS, R. D., BRIGGS, J. M. & MCCAMMON, J. A. (2000). Developing a dynamic phar-macophore model for HIV-1 integrase. Journal of Medicinal Chemistry 43, 2100-2114.
25. CAVASOTTO, C. N. & ABAGYAN, R. A. (2004). Protein flexibility in ligand docking and virtual screening to protein kinases. Journal of Molecular Biology 337, 209-225.
26. CAVASOTTO, C. N., KOVACS, J. A. & ABAGYAN, R. A. (2005). Representing receptor flexibility in ligand docking through relevant normal modes. Journal of the American Chemical Society 127, 9632-9640.
27. CHENG, L.S., AMARO, R.E., XU, D., LI, W.W., ARZBERGER, P.W. & MCCAMMON, J.A. (2008). Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neur-aminidase. Journal of Medicinal Chemistry 51, 3878-3894.
28. CHOPRA, G., SUMMA, C. M. & LEVITT, M. (2008). Solvent dramatically affects protein structure refinement. Proceedings of the National Academy of Sciences USA 105, 20239-20244.
29. CLARK, M., GUARNIERI, F., SHKURKO, I. & WISEMAN, J. (2006). Grand canonical Monte Carlo simulation of ligand-protein binding. Journal of Chemical Information and Modeling 46, 231-242.
30. CLARK, M., MESHKAT, S. & WISEMAN, J. S. (2009). Grand canonical free-energy calculations of protein-ligand binding. Journal of Chemical Information and Modeling 49, 934-943.
31. CLAUSSEN, H., BUNING, C., RAREY, M. & LENGAUER, T. (2001). FlexE: efficient molecular docking considering protein structure variations. Journal of Molecular Biology 308, 377-395.
32. CORBEIL, C. R., ENGLEBIENNE, P. & MOITESSIER, N. (2007). Docking ligands into flexible and solvated macro-molecules. 1. Development and validation of FITTED 1.0. Journal of Chemical Information and Modeling 47, 435-449.
33. CORBEIL, C. R., ENGLEBIENNE, P., YANNOPOULOS, C. G., CHAN, L., DAS, S. K., BILIMORIA, D., L'HEUREUX, L. & MOITESSIER, N. (2008). Docking ligands into flexible and solvated macromolecules. 2. Development and application of FITTED 1.5 to the virtual screening of potential HCV polymerase inhibitors. Journal of Chemical Information and Modeling 48, 902-909.
34. CORBEIL, C. R. & MOITESSIER, N. (2009). Docking ligands into flexible and solvated macromolecules. 3. Impact of input ligand conformation, protein flexibility, and water molecules on the accuracy of docking programs. Journal of Chemical Information and Modeling 49, 997-1009.
35. COZZINI, P., KELLOGG, G. E., SPYRAKIS, F., ABRAHAM, D. J., COSTANTINO, G., EMERSON, A., FANELLI, F., GOHLKE, H., KUHN, L. A., MORRIS, G. M., OROZCO, M., PERTINHEZ, T. A., RIZZI, M. & SOTRIFFER, C. A. (2008). Target flexibility: an emerging consideration in drug discovery and design. Journal of Medicinal Chemistry 51, 6237-6255.
36. CRAIG, I. R., ESSEX, J. W. & SPIEGEL, K. (2010). Ensemble docking into multiple crystallographically derived protein structures: an evaluation based on the statistical analysis of enrichments. Journal of Chemical Information and Modeling 50, 511-524.
37. DAMM, K. L. & CARLSON, H. A. (2007). Exploring experimental sources of multiple protein conformations in structure-based drug design. Journal of the American Chemical Society 129, 8225-8235.
38. DAMM, K. L., UNG, P. M., QUINTERO, J. J., GESTWICKI, J. E. & CARLSON, H. A. (2008). A poke in the eye: inhibiting HIV-1 protease through its flap-recognition pocket. Biopolymers 89, 643-652.
39. DAVIS, I. W. & BAKER, D. (2009). ROSETTALIGAND docking with full ligand and receptor flexibility. Journal of Molecular Biology 385, 381-392.
40. DAVIS, I. W., RAHA, K., HEAD, M. S. & BAKER, D. (2009). Blind docking of pharmaceutically relevant compounds using ROSETTALIGAND. Protein Science 19, 1998-2002.
41. DECHENE, M., WINK, G., SMITH, M., SWARTZ, P. & MATTOS, C. (2009). Multiple solvent crystal structures of ribonu-clease A: an assessment of the method. Proteins 76, 861-881.
42. DUNBAR, J. B., SMITH, R. D., YANG, C.-Y., UNG, P. M. U., LEXA, K. W., KHAZANOV, N. A., STUCKEY, J. A., WANG, S. & CARLSON, H. A. (2011). CSAR benchmark exercise of 2010: selection of the protein-ligand complexes. Journal of Chemical Information and Modeling 51, 2036-2046.
43. DUNBRACK, R. L., Jr. & KARPLUS, M. (1993). Backbone-dependent rotamer library for proteins. Application to side-chain prediction. Journal of Molecular Biology 230, 543-574.
44. DURRANT, J.D., KERANEN, H., WILSON, B.A. & MCCAMMON, J. A. (2010). Computational identification of uncharacterized cruzain binding sites. PLoS Neglected Tropical Diseases 4, e676.
45. DURRANT, J. D. & MCCAMMON, J. A. (2010). Computer-aided drug-discovery techniques that account for receptor flexibility. Current Opinion in Pharmacology 10, 770-774.
46. ENGLEBIENNE, P. & MOITESSIER, N. (2009). Docking li-gands into flexible and solvated macromolecules. 4. Are popular scoring functions accurate for this class of proteins? Journal of Chemical Information and Modeling 49, 1568-1580.
47. ENGLISH, A. C., DONE, S. H., CAVES, L. S. D., GROOM, C. R. & HUBBARD, R. E. (1999). Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% is opropanol. Proteins-Structure Function and Genetics 37, 628-640.
48. ENGLISH, A. C., GROOM, C. R. & HUBBARD, R. E. (2001). Experimental and computational mapping of the binding surface of a crystalline protein. Protein Engineering 14, 47-59.
49. ERLANSON, D. A., MCDOWELL, R. S. & O'BRIEN, T. (2004). Fragment-based drug discovery. Journal of Medicinal Chemistry 47, 3463-3482.
50. EYAL, E., GERZON, S., POTAPOV, V., EDELMAN, M. & SOBOLEV, V. (2005). The limit of accuracy of protein modeling: influence of crystal packing on protein structure. Journal of Molecular Biology 351, 431-442.
51. FEDOROV, A.A., JOSEPH-MCCARTHY, D., FEDOROV, E., SIRAKOVA, D., GRAF, I. & ALMO, S. C. (1996). Ionic interactions in crystalline bovine pancreatic ribonuclease A. Biochemistry 35, 15962-15979.
52. FERRARI, A. M., WEI, B. Q., COSTANTINO, L. & SHOICHET, B. K. (2004). Soft docking and multiple receptor conformations in virtual screening. Journal of Medicinal Chemistry 47, 5076-5084.
53. FIRTH-CLARK, S., WILLEMS, H. M., WILLIAMS, A. & HARRIS, W. (2006). Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen. Journal of Chemical Information and Modeling 46, 642-647.
54. FISCHER, E. (1890). Synthese des traubenzuckers. Berichte der deutschen chemischen Gesellschaft 23, 799-805.
55. FITZPATRICK, P.A., STEINMETZ, A.C., RINGE, D. & KLIBANOV, A. M. (1993). Enzyme crystal structure in a neat organic solvent. Proceedings of the National Academy of Sciences of the United States of America 90, 8653-8657.
56. FOOTE, J. & MILSTEIN, C. (1994). Conformational isomer-ism and the diversity of antibodies. Proceedings of the National Academy of Sciences of the United States of America 91, 10370-10374.
57. FREMBGEN-KESNER, T. & ELCOCK, A.H. (2006). Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase. Journal of Molecular Biology 359, 202-214.
58. FUENTES, G., DASTIDAR, S. G., MADHUMALAR, A. & VERMA, C. S. (2011). Role of protein flexibility in the discovery of new drugs. Drug Development Research 72, 26-35.
59. GUNASEKARAN, K., MA, B. & NUSSINOV, R. (2004). Is al-lostery an intrinsic property of all dynamic proteins ? Proteins 57, 433-443.
60. GUVENCH, O. & MACKERELL, A.D., Jr. (2009). Computational fragment-based binding site identification by ligand competitive saturation. PLoS Computational Biology 5, e1000435.
61. HAMMES, G.G., CHANG, Y. C. & OAS, T.G. (2009). Conformational selection or induced fit: a flux description of reaction mechanism. Proceedings of the National Academy of Sciences of the United States of America 106, 13737-13741.
62. HARTSHORN, M.J., VERDONK, M.L., CHESSARI, G., BREWERTON, S. C., MOOIJ, W. T., MORTENSON, P. N. & MURRAY, C. W. (2007). Diverse, high-quality test set for the validation of protein-ligand docking performance. Journal of Medicinal Chemistry 50, 726-741.
63. HENZLER, A. M. & RAREY, M. (2010). In pursuit of fully flexible protein-ligand docking: modeling the bilateral mechanism of binding. Molecular Informatics 29, 164-173.
64. HO, W.C., LUO, C., ZHAO, K.H., CHAI, X.M., FITZGERALD, M. X. & MARMORSTEIN, R. (2006). Highresolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds. Acta Crystallographica Section D Biological Crystallography 62, 1484-1493.
65. HOWARD, S., BERDINI, V., BOULSTRIDGE, J. A., CARR, M. G., CROSS, D. M., CURRY, J., DEVINE, L. A., EARLY, T. R., FAZAL, L., GILL, A. L., HEATHCOTE, M., MAMAN, S., MATTHEWS, J. E., MCMENAMIN, R. L., NAVARRO, E. F., O'BRIEN, M. A., O'REILLY, M., REES, D. C., REULE, M., TISI, D., WILLIAMS, G., VINKOVIC, M. & WYATT, P. G. (2009). Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. Journal of Medicinal Chemistry 52, 379-388.
66. HUANG, S. Y., GRINTER, S. Z. & ZOU, X. (2010). Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions. Physical Chemistry Chemical Physics 12, 12899-12908.
67. HUANG, Z. & WONG, C. F. (2009). Docking flexible peptide to flexible protein by molecular dynamics using two implicit-solvent models: an evaluation in protein kinase and phosphatase systems. Journal of Physical Chemistry B 113, 14343-14354.
68. HUANG, S. Y. & ZOU, X. (2007). Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 66, 399-421.
69. JAIN, A. N. (2003). Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry 46, 499-511.
70. JAIN, A. N. (2007). Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. Journal of Computer-Aided Molecular Design 21, 281-306.
71. JAIN, A. N. (2009). Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation. Journal of Computer-Aided Molecular Design 23, 355-374.
72. JIANG, F. & KIM, S. H. (1991). ''Soft docking'': matching of molecular surface cubes. Journal of Molecular Biology 219, 79-102.
73. JORGENSEN, W. L. (2004). The many roles of computation in drug discovery. Science 303, 1813-1818.
74. JOSEPH-MCCARTHY, D., FEDOROV, A.A. & ALMO, S. C. (1996). Comparison of experimental and computational functional group mapping of an RNase A structure: implications for computer-aided drug design. Protein Engineering 9, 773-780.
75. KAIRYS, V. & GILSON, M. K. (2002). Enhanced docking with the mining minima optimizer: acceleration and side-chain flexibility. Journal of Computational Chemistry 23, 1656-1670.
76. KALLBLAD, P. & DEAN, P. M. (2003). Efficient conforma-tional sampling of local side-chain flexibility. Journal of Molecular Biology 326, 1651-1665.
77. KASTENHOLZ, M. A., PASTOR, M., CRUCIANI, G., HAAKSMA, E. E. & FOX, T. (2000). GRID/CPCA: a new computational tool to design selective ligands. Journal of Medicinal Chemistry 43, 3033-3044.
78. KESERU, G. M. & KOLOSSVARY, I. (2001). Fully flexible low-mode docking: application to induced fit in HIV in-tegrase. Journal of the American Chemical Society 123, 12708-12709.
79. KLEBE, G. (2006). Virtual ligand screening: strategies, perspectives and limitations. Drug Discovery Today 11, 580-594.
80. KNEGTEL, R. M., KUNTZ, I. D. & OSHIRO, C. M. (1997). Molecular docking to ensembles of protein structures. Journal of Molecular Biology 266, 424-440.
81. KOLLMAN, P. A., MASSOVA, I., REYES, C., KUHN, B., HUO, S., CHONG, L., LEE, M., LEE, T., DUAN, Y., WANG, W., DONINI, O., CIEPLAK, P., SRINIVASAN, J., CASE, D.A. & CHEATHAM, T. E. (2000). Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Accounts of Chemical Research 33, 889-897.
82. KOSHLAND, D. E. (1958). Application of a theory of enzyme specificity to protein synthesis. Proceedings of the National Academy of Sciences of the United States of America 44, 98-104.
83. KRANJC, A., BONGARZONE, S., ROSSETTI, G., BIARNES, X., CAVALLI, A., BOLOGNESI, M. L., ROBERTI, M., LEGNAME, G. & CARLONI, P. (2009). Docking ligands on protein surfaces: the case study of prion protein. Journal of Chemical Theory and Computation 5, 2565-2573.
84. KUMAR, S., MA, B., TSAI, C. J., SINHA, N. & NUSSINOV, R. (2000). Folding and binding cascades: dynamic landscapes and population shifts. Protein Science 9, 10-19.
85. LANDON, M. R., AMARO, R. E., BARON, R., NGAN, C. H., OZONOFF, D., MCCAMMON, J. A. & VAJDA, S. (2008). Novel druggable hot spots in avian influenza neur-aminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chemical Biology and Drug Design 71, 106-116.
86. LAUGHTON, C. A., OROZCO, M. & VRANKEN, W. (2009). COCO: a simple tool to enrich the representation of conformational variability in NMR structures. Proteins 75, 206-216.
87. LEACH, A. R. (1994). Ligand docking to proteins with discrete side-chain flexibility. Journal of Molecular Biology 235, 345-356.
88. LEACH, A. R., SHOICHET, B. K. & PEISHOFF, C. E. (2006). Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. Journal of Medicinal Chemistry 49, 5851-5855.
89. LEONG, M. K. (2007). A novel approach using pharmaco-phore ensemble/support vector machine (phe/svm) for prediction of hERG liability. Chemical Research in Toxicology 20, 217-226.
90. LEONG, M. K. & CHEN, T. H. (2008). Prediction of cyto-chrome P450 2B6-substrate interactions using pharma-cophore ensemble/support vector machine (PhE/SVM) approach. Medicinal Chemistry 4, 396-406.
91. LEONG, M. K., CHEN, Y. M., CHEN, H. B. & CHEN, P. H. (2009). Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach. Pharmaceutical Research 26, 987-1000.
92. LEXA, K. W. & CARLSON, H. A. (2011). Full protein flexibility is essential for proper hot-spot mapping. Journal of the American Chemical Society 133, 200-202.
93. LIN, J.H., PERRYMAN, A.L., SCHAMES, J.R. & MCCAMMON, J. A. (2002). Computational drug design accommodating receptor flexibility: the relaxed complex scheme. Journal of the American Chemical Society 124, 5632-5633.
94. LIN, J. H., PERRYMAN, A. L., SCHAMES, J. R. & MCCAMMON, J. A. (2003). The relaxed complex method: accommodating receptor flexibility for drug design with an improved scoring scheme. Biopolymers 68, 47-62.
95. LINDAHL, E. & DELARUE, M. (2005). Refinement of docked protein-ligand and protein-DNA structures using low frequency normal mode amplitude optimization. Nucleic Acids Research 33, 4496-4506.
96. MARTI-RENOM, M. A., STUART, A. C., FISER, A., SANCHEZ, R., MELO, F. & SALI, A. (2000). Comparative protein structure modeling of genes and genomes. Annual Reviews of Biophysics and Biomolecular Structure 29, 291-325.
97. MATTOS, C. & RINGE, D. (1996). Locating and characterizing binding sites on proteins. Nature Biotechnology 14, 595-599.
98. MAY, A., SIEKER, F. & ZACHARIAS, M. (2008). How to efficiently include receptor flexibility during computational docking. Current Computer-Aided Drug Design 4, 143-153.
99. MAY, A. & ZACHARIAS, M. (2005). Accounting for global protein deformability during protein-protein and pro-tein-ligand docking. Biochimica and Biophysica Acta 1754, 225-231.
100. MAY, A. & ZACHARIAS, M. (2008). Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking. Journal of Medicinal Chemistry 51, 3499-3506.
101. MCCAMMON, J. A. (2005). Target flexibility in molecular recognition. Biochimica and Biophysica Acta 1754, 221-224.
102. MEILER, J. & BAKER, D. (2006). ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. Proteins 65, 538-548.
103. MIRANKER, A. & KARPLUS, M. (1991). Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 11, 29-34.
104. MIZUTANI, M. Y., TAKAMATSU, Y., ICHINOSE, T., NAKAMURA, K. & ITAI, A. (2006). Effective handling of induced-fit motion in flexible docking. Proteins 63, 878-891.
105. MOBLEY, D. L. & DILL, K. A. (2009). Binding of small-molecule ligands to proteins: ''What you see'' is not always ''what you get''. Structure 17, 489-498.
106. MOITESSIER, N., ENGLEBIENNE, P., LEE, D., LAWANDI, J. & CORBEIL, C. R. (2008). Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. British Journal of Pharmacology 153 (Suppl. 1), S7-26.
107. MONOD, J., WYMAN, J. & CHANGEUX, J. P. (1965). On the nature of allosteric transitions: a plausible model. Journal of Molecular Biology 12, 88-118.
108. MOORE, W. R., Jr. (2005). Maximizing discovery efficiency with a computationally driven fragment approach. Current Opinion in Drug Discovery and Development 8, 355-364.
109. MORRIS, G. M., HUEY, R., LINDSTROM, W., SANNER, M. F., BELEW, R. K., GOODSELL, D. S. & OLSON, A. J. (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry 30, 2785-2781.
110. MUKHERJEE, S., BALIUS, T. E. & RIZZO, R.C. (2010). Docking validation resources: protein family and ligand flexibility experiments. Journal of Chemical Information and Modeling 50, 1986-2000.
111. MURRAY, C. W., BAXTER, C. A. & FRENKEL, A. D. (1999). The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, thermolysin and neuraminidase. Journal of Computer-Aided Molecular Design 13, 547-562.
112. MURRAY, C. W. & REES, D. C. (2009). The rise of fragment-based drug discovery. Nature Chemistry 1, 187-192.
113. MUSTATA, G. I. & BRIGGS, J. M. (2002). A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase. Journal of Computer-Aided Molecular Design 16, 935-953.
114. MUSTATA, G. I., SOARES, T. A. & BRIGGS, J. M. (2003). Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers 70, 186-200.
115. NABUURS, S. B., WAGENER, M. & DE VLIEG, J. (2007). A flexible approach to induce fit docking. Journal of Medicinal Chemistry 50, 6507-6518.
116. NAJMANOVICH, R., KUTTNER, J., SOBOLEV, V. & EDELMAN, M. (2000). Side-chain flexibility in proteins upon ligand binding. Proteins 39, 261-268.
117. NICHOLS, S. E., BARON, R., IVETAC, A. & MCCAMMON, J. A. (2011). Predictive power of molecular dynamics receptor structures in virtual screening. Journal of Chemical Information and Modeling 51, 1439-1446.
118. OSTERBERG, F., MORRIS, G.M., SANNER, M.F., OLSON, A. J. & GOODSELL, D. S. (2002). Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins 46, 34-40.
119. OTA, N. & AGARD, D. A. (2001). Binding mode prediction for a flexible ligand in a flexible pocket using multi-conformation simulated annealing pseudo crystal-lographic refinement. Journal of Molecular Biology 314, 607-617.
120. PENCHEVA, T., LAGORCE, D., PAJEVA, I., VILLOUTREIX, B. O. & MITEVA, M. A. (2008). AMMOS: automated molecular mechanics optimization tool for in silico screening. BMC Bioinformatics 9, 438.
121. PERRYMAN, A. L., LIN, J. H. & MCCAMMON, J. A. (2006). Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design. Chemical Biology and Drug Design 67, 336-345.
122. PHILIPPOPOULOS, M. & LIM, C. (1999). Exploring the dynamic information content of a protein NMR structure: comparison of a molecular dynamics simulation with the NMR and X-ray structures of Escherichia coli ribonuclease HI. Proteins 36, 87-110.
123. PLEWCZYNSKI, D., LAZNIEWSKI, M., AUGUSTYNIAK, R. & GINALSKI, K. (2011). Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database. Journal of Computational Chemistry 32, 742-755.
124. POPOV, V. M., YEE, W. A. & ANDERSON, A. C. (2007). Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity. Proteins 66, 375-387.
125. RAMAN, E. P., YU, W., GUVENCH, O. & MACKERELL, A. D. (2011). Reproducing crystal binding modes of ligand functional groups using site-identification by ligand competitive saturation (SILCS) simulations. Journal of Chemical Information and Modeling 51, 877-896.
126. RAO, C. B., SUBRAMANIAN, J. & SHARMA, S. D. (2009). Managing protein flexibility in docking and its applications. Drug Discovery Today 14, 394-400.
127. RAREY, M., KRAMER, B., LENGAUER, T. & KLEBE, G. (1996). A fast flexible docking method using an incremental construction algorithm. Journal of Molecular Biology 261, 470-489.
128. RUEDA, M., BOTTEGONI, G. & ABAGYAN, R. (2009). Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes. Journal of Chemical Information and Modeling 49, 716-725.
129. RUEDA, M., BOTTEGONI, G. & ABAGYAN, R. (2010). Recipes for the selection of experimental protein conformations for virtual screening. Journal of Chemical Information and Modeling 50, 186-193.
130. SCHAFFERHANS, A. & KLEBE, G. (2001). Docking ligands onto binding site representations derived from proteins built by homology modelling. Journal of Molecular Biology 307, 407-427.
131. SCHMITKE, J. L., STERN, L. J. & KLIBANOV, A. M. (1997). The crystal structure of subtilisin Carlsberg in anhydrous dioxane and its comparison with those in water and acetonitrile. Proceedings of the National Academy of Sciences of the United States of America 94, 4250-4255.
132. SCHMITKE, J. L., STERN, L. J. & KLIBANOV, A. M. (1998). Comparison of x-ray crystal structures of an acyl-enzyme intermediate of subtilisin Carlsberg formed in anhydrous acetonitrile and in water. Proceedings of the National Academy of Sciences of the United States of America 95, 12918-12923.
133. SCHNECKE, V. & KUHN, L. A. (2000). Virtual screening with solvation and ligand-induced complementarity. Perspectives in Drug Discovery and Design 20, 171-190.
134. SCHUBERT, C. R. & STULTZ, C. M. (2009). The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design. Journal of Computer-Aided Molecular Design 23, 475-489.
135. SECO, J., LUQUE, F. J. & BARRIL, X. (2009). Binding site detection and druggability index from first principles. Journal of Medicinal Chemistry 52, 2363-2371.
136. SHERMAN, W., BEARD, H. S. & FARID, R. (2006a). Use of an induced fit receptor structure in virtual screening. Chemical Biology and Drug Design 67, 83-84.
137. SHERMAN, W., DAY, T., JACOBSON, M. P., FRIESNER, R. A. & FARID, R. (2006b). Novel procedure for modeling li-gand/receptor induced fit effects. Journal of Medicinal Chemistry 49, 534-553.
138. SHUKER, S.B., HAJDUK, P. J., MEADOWS, R. P. & FESIK, S. W. (1996). Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531-1534.
139. SMITH, L. J., REDFIELD, C., SMITH, R. A., DOBSON, C. M., CLORE, G. M., GRONENBORN, A. M., WALTER, M. R., NAGANBUSHAN, T.L. & WLODAWER, A. (1994). Comparison of four independently determined structures of human recombinant interleukin-4. Nature Structural Biology 1, 301-310.
140. SMITH, R. D., DUNBAR, J. B., JR., UNG, P. M. U., ESPOSITO, E. X., YANG, C.-Y., WANG, S. & CARLSON, H. A. (2011). CSAR benchmark exercise of 2010: combined evaluation across all submitted scoring functions. Journal of Chemical Information and Modeling 51(9), 2036-2046.
141. SOTRIFFER, C. A. (2011). Accounting for induced-fit effects in docking: what is possible and what is not? Current Topics in Medicinal Chemistry 11, 179-191.
142. SOUSA, S. F., FERNANDES, P. A. & RAMOS, M. J. (2006). Protein-ligand docking: current status and future challenges. Proteins 65, 15-26.
143. SPERANDIO, O., MOUAWAD, L., PINTO, E., VILLOUTREIX, B. O., PERAHIA, D. & MITEVA, M. A. (2010). How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis. European Biophysics Journal 39, 1365-1372.
144. STULTZ, C. M. & KARPLUS, M. (1999). MCSS functionality maps for a flexible protein. Proteins 37, 512-529.
145. SUBRAMANIAN, J., SHARMA, S. & B-RAO, C. (2006). A novel computational analysis of ligand-induced conforma-tional changes in the ATP binding sites of cyclin dependent kinases. Journal of Medicinal Chemistry 49, 5434-5441.
146. SUBRAMANIAN, J., SHARMA, S. & B-RAO, C. (2008). Modeling and selection of flexible proteins for structure-based drug design: backbone and side chain movements in p38 MAPK. ChemMedChem 3, 336-344.
147. SULLIVAN, S. M. & HOLYOAK, T. (2008). Enzymes with lid-gated active sites must operate by an induced fit mechanism instead of conformational selection. Proceedings of the National Academy of Sciences of the United States of America 105, 13829-13834.
148. SWEENEY, Z. K., HARRIS, S. F., ARORA, N., JAVANBAKHT, H., LI, Y., FRETLAND, J., DAVIDSON, J. P., BILLEDEAU, J. R., GLEASON, S. K., HIRSCHFELD, D., KENNEDY-SMITH, J. J., MIRZADEGAN, T., ROETZ, R., SMITH, M., SPERRY, S., SUH, J. M., WU, J., TSING, S., VILLASEÑOR, A. G., PAUL, A., SU, G., HEILEK, G., HANG, J.Q., ZHOU, A.S., JERNELIUS, J. A., ZHANG, F-J. & KLUMPP, K. (2008). Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase. Journal of Medicinal Chemistry 51, 7449-7458.
149. TAFT, C. A., DA SILVA, V. B. & DA SILVA, C. H. (2008). Current topics in computer-aided drug design. Journal of Pharmaceutical Sciences 97, 1089-1098.
150. TALELE, T. T., KHEDKAR, S. A. & RIGBY, A. C. (2010). Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. Current Topics in Medicinal Chemistry 10, 127-141.
151. TAYLOR, R. D., JEWSBURY, P. J. & ESSEX, J. W. (2003). FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function. Journal of Computational Chemistry 24, 1637-1656.
152. TEAGUE, S. J. (2003). Implications of protein flexibility for drug discovery. Nature Reviews Drug Discovery 2, 527-541.
153. TEODORO, M. L. & KAVRAKI, L. E. (2003). Conformational flexibility models for the receptor in structure based drug design. Current Pharmaceutical Design 9, 1635-1648.
154. TOTROV, M. & ABAGYAN, R. (2008). Flexible ligand docking to multiple receptor conformations: a practical alternative. Current Opinions in Structural Biology 18, 178-184.
155. TSAI, C. J., KUMAR, S., MA, B. & NUSSINOV, R. (1999a). Folding funnels, binding funnels, and protein function. Protein Science 8, 1181-1190.
156. TSAI, C. J., MA, B. & NUSSINOV, R. (1999b). Folding and binding cascades: shifts in energy landscapes. Proceedings of the National Academy of Sciences of the United States of America 96, 9970-9972.
157. TSAI, C. J., MA, B., SHAM, Y. Y., KUMAR, S. & NUSSINOV, R. (2001). Structured disorder and conformational selection. Proteins 44, 418-427.
158. VAN WESTEN, G.J.P., WEGNER, J.K., BENDER, A., IJZERMAN, A. P. & VAN VLIJMEN, H. W. T. (2010). Mining protein dynamics from sets of crystal structures using ''consensus structures ''. Protein Science 19, 742-752.
159. VELEC, H.F., GOHLKE, H. & KLEBE, G. (2005). DrugScore(CSD)-knowledge- based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction. Journal of Medicinal Chemistry 48, 6296-6303.
160. VERDONK, M.L., MORTENSON, P.N., HALL, R.J., HARTSHORN, M. J. & MURRAY, C. W. (2008). Protein-ligand docking against non-native protein conformers. Journal of Chemical Information and Modeling 48, 2214-2225.
161. WANG, Z., ZHU, G., HUANG, Q., QIAN, M., SHAO, M., JIA, Y. & TANG, Y. (1998). X-ray studies on cross-linked lysozyme crystals in acetonitrile-water mixture. Biochimica and Biophysica Acta 1384, 335-344.
162. WARREN, G. L., ANDREWS, C. W., CAPELLI, A. M., CLARKE, B., LALONDE, J., LAMBERT, M. H., LINDVALL, M., NEVINS, N., SEMUS, S. F., SENGER, S., TEDESCO, G., WALL, I. D., WOOLVEN, J. M., PEISHOFF, C. E. & HEAD, M. S. (2006). A critical assessment of docking programs and scoring functions. Journal of Medicinal Chemistry 49, 5912-5931.
163. WEI, B. Q., WEAVER, L. H., FERRARI, A. M., MATTHEWS, B. W. & SHOICHET, B. K. (2004). Testing a flexible-receptor docking algorithm in a model binding site. Journal of Molecular Biology 337, 1161-1182.
164. WEIKL, T. R. & VON DEUSTER, C. (2009). Selected-fit versus induced-fit protein binding: kinetic differences and mutational analysis. Proteins 75, 104-110.
165. WIESMANN, C., BARR, K. J., KUNG, J., ZHU, J., ERLANSON, D. A., SHEN, W., FAHR, B. J., ZHONG, M., TAYLOR, L., RANDAL, M., MCDOWELL, R. S. & HANSEN, S. K. (2004). Allosteric inhibition of protein tyrosine phosphatase 1B. Nature Structural and Molecular Biology 11, 730-737.
166. WONG, S. & JACOBSON, M. P. (2008). Conformational selection in silico: loop latching motions and ligand binding in enzymes. Proteins 71, 153-164.
167. YANG, C. & WANG, S. (2010). Computational analysis of protein hotspots. ACS Medicinal Chemistry Letters 1, 125-129.
168. YANG, L.W., EYAL, E., CHENNUBHOTLA, C., JEE, J., GRONENBORN, A. M. & BAHAR, I. (2007). Insights into equilibrium dynamics of proteins from comparison of NMR and X-ray data with computational predictions. Structure 15, 741-749.
169. ZACHARIAS, M. (2004). Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP. Proteins: Structure, Function, and Bioinformatics 54, 759-767.
170. ZACHARIAS, M. (2008). Combining elastic network analysis and molecular dynamics simulations by hamiltonian replica exchange. Journal of Chemical Theory and Computation 4, 477-487.
171. ZACHARIAS, M. & SKLENAR, H. (1999). Harmonic modes as variables to approximately account for receptor flexibility in ligand-receptor docking simulations: application to DNA minor groove ligand complex. Journal of Computational Chemistry 20, 287-300.
172. ZAVODSZKY, M. I. & KUHN, L. A. (2005). Side-chain flexibility in protein-ligand binding: the minimal rotation hypothesis. Protein Science 14, 1104-1114.
173. ZAVODSZKY, M. I., LEI, M., THORPE, M. F., DAY, A. R. & KUHN, L. A. (2004). Modeling correlated main-chain motions in proteins for flexible molecular recognition. Proteins: Structure, Function, and Bioinformatics 57, 243-261.
174. ZAVODSZKY, M. I., SANSCHAGRIN, P. C., KORDE, R. S. & KUHN, L. A. (2002). Distilling the essential features of a protein surface for improving protein-ligand docking, scoring, and virtual screening. Journal of Computer-Aided Molecular Design 16, 883-902.
175. ZENTGRAF, M., FOKKENS, J. & SOTRIFFER, C. A. (2006). Addressing protein flexibility and ligand selectivity by ''in situ cross-docking''. ChemMedChem 1, 1355-1359.
176. ZENTGRAF, M., STEUBER, H., KOCH, C., LA MOTTA, C., SARTINI, S., SOTRIFFER, C. A. & KLEBE, G. (2007). How reliable are current docking approaches for structure-based drug design? Lessons from aldose reductase. Angewandte Chemie 46, 3575-3578.
177. ZHAO, Y. & SANNER, M. F. (2007). FLIPDock: docking flexible ligands into flexible receptors. Proteins: Structure, Function, and Bioinformatics 68, 726-737.
178. ZHAO, Y. & SANNER, M. F. (2008). Protein-ligand docking with multiple flexible side chains. Journal of Computer-Aided Molecular Design 22, 673-679.
179. ZHU, J., FAN, H., LIU, H. & SHI, Y. (2001). Structure-based ligand design for flexible proteins: application of new F-DycoBlock. Journal of Computer-Aided Molecular Design 15, 979-996.